[Efficacy of rescue extracorporeal membrane oxygenation combined with delayed left ventricular assist device implantation for in-hospital sudden cardiac arrest in end-stage heart failure patients].
Y, S., Y, D., QS, W., XF, D., GC, Z., & LW, C. (2026). [Efficacy of rescue extracorporeal membrane oxygenation combined with delayed left ventricular assist device implantation for in-hospital sudden cardiac arrest in end-stage heart failure patients].. Zhonghua yi xue za zhi. https://doi.org/10.3760/cma.j.cn112137-20260202-00364
Y S, Y D, QS W, XF D, GC Z, LW C. [Efficacy of rescue extracorporeal membrane oxygenation combined with delayed left ventricular assist device implantation for in-hospital sudden cardiac arrest in end-stage heart failure patients].. Zhonghua yi xue za zhi. 2026; doi: 10.3760/cma.j.cn112137-20260202-00364
Y S, Y D, QS W, et al. [Efficacy of rescue extracorporeal membrane oxygenation combined with delayed left ventricular assist device implantation for in-hospital sudden cardiac arrest in end-stage heart failure patients].[J]. Zhonghua yi xue za zhi. 2026. DOI: 10.3760/cma.j.cn112137-20260202-00364.
@article{y2026,
author = {Shen Y and Dong Y and Wu QS and Dai XF and Zhang GC and Chen LW},
title = {[Efficacy of rescue extracorporeal membrane oxygenation combined with delayed left ventricular assist device implantation for in-hospital sudden cardiac arrest in end-stage heart failure patients].},
journal = {Zhonghua yi xue za zhi},
year = {2026},
doi = {10.3760/cma.j.cn112137-20260202-00364},
note = {PMID: 42595513},
}
TY - JOUR AU - Shen Y AU - Dong Y AU - Wu QS AU - Dai XF AU - Zhang GC AU - Chen LW TI - [Efficacy of rescue extracorporeal membrane oxygenation combined with delayed left ventricular assist device implantation for in-hospital sudden cardiac arrest in end-stage heart failure patients]. T2 - Zhonghua yi xue za zhi PY - 2026 DO - 10.3760/cma.j.cn112137-20260202-00364 AN - PMID:42595513 ER -
The data of eight patients with end-stage heart failure who experienced in-hospital sudden cardiac arrest and received cardiopulmonary resuscitation (CPR), followed by extracorporeal membrane oxygenation (ECMO) combined with delayed left ventricular assist device (LVAD) implantation in Fujian Medical University Union Hospital from January 2022 to June 2025 were retrospectively reviewed. Among them, there were seven males and one female, with a median age of 56 (50, 63) years. The etiologies included ischemic cardiomyopathy (five cases), dilated cardiomyopathy (two cases) and low cardiac output syndrome after severe valvular heart disease surgery (one case). All patients were stabilized by ECMO rescue before LVAD implantation, with an ECMO support time of 9.5 (6.5, 12.0) days. All surgeries were performed under general anesthesia with cardiopulmonary bypass. Postoperatively, six cases discharged smoothly, two cases died in hospital, and one case developed cerebral infarction which recovered after interventional thrombectomy. For discharged patients, follow-up was conducted at 1, 3, 6 and 12 months, the mechanical pump functioned normally, and cardiac function was significantly improved. The study suggests that ECMO can stabilize the condition of these high-risk patients, and bridging to LVAD can relieve the pressure on the donor heart and improve prognosis. 回顾性纳入2022年1月至2025年6月福建医科大学附属协和医院8例心源性猝死心肺复苏后接受体外膜肺氧合（ECMO）并桥接左心室辅助装置（LVAD）植入治疗的终末期心力衰竭患者。其中男7例，女1例，年龄56（50，63）岁，包括缺血性心肌病5例、扩张型心肌病2例及重症瓣膜病术后低心排血量综合征1例。所有患者经ECMO抢救稳定后行LVAD植入，ECMO支持时间9.5（6.5，12.0）d，手术均在全身麻醉体外循环下进行，术后6例顺利出院，2例院内死亡，1例并发脑梗死经治疗后恢复。患者出院后1、3、6、12个月随访，机械泵运转正常，心功能明显改善。研究结果提示，ECMO可稳定此类高危患者病情，桥接LVAD能缓解供心压力并改善预后。.